Laurus Labs Limited vs Syncom Formulations (India) Limited
A side-by-side comparison of Laurus Labs Limited (LAURUSLABS) and Syncom Formulations (India) Limited (SYNCOMF) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Syncom Formulations (India) Limited leads LAURUSLABS vs SYNCOMF on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation13
- Profitability22
- Growth02
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
SYNCOMF takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
SYNCOMF takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
LAURUSLABS takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + []
- − ["Stock is trading at 20.99 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
- + ["Company has delivered good profit growth of 21.4% CAGR over last 5 years", "Company is almost debt free."]
- − []
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.